An Open-Labeled, Non-Randomized Phase I Study of Safingol Administered With Cisplatin in Patients With Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 21 Mar 2013
At a glance
- Drugs Safingol (Primary) ; Cisplatin
- Indications Solid tumours
- Focus Adverse reactions
- 07 Mar 2009 Status changed from recruiting to completed, according to ClinicalTrials.gov.
- 01 Apr 2008 The expected completion date for this trial is now 1 Mar 2010, from clinicaltrials.gov record.
- 22 Aug 2005 New trial record.